Aryzta AG
ARZTY · OTC
12/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 16.86 | -0.76 | -183.90 | 0.49 |
| FCF Yield | 1.09% | 0.95% | 1.31% | 0.00% |
| EV / EBITDA | 57.39 | 75.35 | 53.94 | 51.63 |
| Quality | ||||
| ROIC | 11.62% | 9.22% | 0.26% | -1.10% |
| Gross Margin | 21.38% | 18.48% | 18.14% | 16.55% |
| Cash Conversion Ratio | 2.31 | 2.24 | 222.33 | -0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.71% | 11.65% | 1.71% | -23.32% |
| Free Cash Flow Growth | 3.70% | 68.92% | 38,833.33% | 100.42% |
| Safety | ||||
| Net Debt / EBITDA | 2.17 | 1.41 | 1.70 | 1.11 |
| Interest Coverage | 3.41 | 4.57 | 2.61 | -0.35 |
| Efficiency | ||||
| Inventory Turnover | 13.48 | 13.80 | 11.94 | 13.76 |
| Cash Conversion Cycle | -3.73 | -24.17 | 0.09 | 7.49 |